Accurate diagnosis and classification of patients with RA at presentation |
Early assessment of bony erosions to define patients who already have articular structural damage |
Quantification of synovial inflammation at the primary site, potentially allowing prediction of further erosions and disease progression |
Simultaneous assessment of synovitis and joint erosion pathologies, allowing for dissection of the relative importance of these two pathologies in RA disease progression |
Long-term evaluation of treatment outcome in clinical trials and real-world settings |